STAT

Opinion: Pork farming: the next battlefield for fighting antibiotic resistance

In its four-month journey from piglet to slaughter, each of the nearly 1 billion pigs on the planet will consume 2.5 times the amount of antibiotics as the average European…
Source: GREG BAKER/AFP/Getty Images

McDonald’s recently announced it will begin phasing out the use of medically important antibiotics in its global beef supply chain, building on its experience phasing out such antibiotics from its chicken supply. Other retail food chains have also made progress. Now it’s time to take aim at pork.

McDonald’s promise is a commendable step in addressing antimicrobial resistance, one of our most pressing global health challenges. It’s also an important signal that consumers hold power to shift food industry practices toward sustainability.

Nearly a century ago, Alexander Fleming’s discovery of penicillin launched modern medical practice into the antibiotic era. His discovery, and those that followed, are credited with saving untold millions of lives and enabling landmark medical breakthroughs. Yet decades of inattentive use — for purposes as different as treating viral infections, for which antibiotics are ineffective, to the industrial production of beef, chicken, pork, and seafood — now risks throwing away the

Stai leggendo un'anteprima, registrati per continuare a leggere.

Altro da STAT

STAT1 min lettiMedical
STAT+: Pharmalittle: Pause For J&J Covid-19 Shot To Continue At Least A Week; Biden Expands Candidate List For FDA Commish
The U.S. government pause on use of the Johnson & Johnson Covid-19 vaccine is unlikely to be lifted for at least another week or 10 days.
STAT1 min lettiMedical
STAT+: Pharmalittle: FDA Panel Endorses Moderna Covid-19 Vaccine; Sacklers Dodge Blame For Opioid Crisis At Hearing
An FDA advisory panel recommended the agency issue an emergency use authorization for the Moderna Covid-19 vaccine, all but guaranteeing the agency will do so.
STAT1 min lettiMedical
STAT+: Pharmalittle: An Arthritis Drug Reduced Covid-19 Death Rates; Impatience Grows Over Choosing FDA Commissioner
Tocilizumab, a drug usually used to treat rheumatoid arthritis, reduced the rate of death in hospitalized Covid-19 patients in a major clinical trial.